Sachem Capital Corp. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Sachem Capital Corp. on April 13, 2021, covering events occurring on April 8 and April 9, 2021. The Company is a business development company incorporated in New York.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. It focuses on corporate actions regarding equity issuance and executive compensation.
Material Changes and Corporate Actions
- At-Market Issuance Sales Agreement: On April 9, 2021, the Company entered into an agreement with Ladenburg Thalmann & Co., Inc. and Janney Montgomery Scott LLC to sell up to $43,636,250 of common shares via an "at-the-market" offering. The agents may receive commissions of up to 2.0% on sales.
- Executive Compensation Adjustments: The Compensation Committee approved 2021 compensation packages for CEO John L. Villano and CFO Peter J. Cuozzo based on independent expert recommendations.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, outlook, or management commentary regarding future financial performance. The primary risk disclosed relates to the potential dilution of existing shareholders if the Company exercises its option to sell shares under the new Sales Agreement, though the Company has no obligation to sell any shares.
Executive Compensation Details
| Executive | Base Salary (2021) | Target/One-Time Bonus | Equity Award (Value) | Shares Issued |
|---|---|---|---|---|
| John L. Villano (CEO) | $500,000 | $250,000 (Target) + $250,000 (One-time) | $500,000 | 89,928 |
| Peter J. Cuozzo (CFO) | $250,000 | $25,000 (One-time) | $25,000 | 4,753 |
Equity awards vest one-third annually on January 1, 2022, 2023, and 2024.
Investor Verification Checklist
- Verify the current market price of Sachem Capital Corp. common shares to assess the potential dilution impact of the $43.6 million at-the-market offering.
- Review the full text of the At Market Issuance Sales Agreement (Exhibit 1.1) for specific termination rights and conditions.
- Confirm the vesting schedule and forfeiture provisions for the restricted stock granted to executives.
- Check subsequent filings to determine if any shares have actually been sold under the new Sales Agreement.